AbbVie Inc. P/E Ratio 2011–2025
AbbVie Inc. reported 94.58 of price-to-earnings ratio for fiscal 2025. That was 34.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +198.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 94.58 | +34.8% |
| FY 2024 | 70.18 | +35.3% |
| FY 2023 | 51.88 | +143.2% |
| FY 2022 | 21.33 | +20.6% |
| FY 2021 | 17.68 | -44.2% |
| FY 2020 | 31.67 | +147.9% |
| FY 2019 | 12.77 | -29.7% |
| FY 2018 | 18.16 | -10.7% |
| FY 2017 | 20.34 | +76.1% |
| FY 2016 | 11.55 | -5.3% |
| FY 2015 | 12.20 | -67.1% |
| FY 2014 | 37.13 | +197.7% |
| FY 2013 | 12.47 | — |
| FY 2012 | — | — |
| FY 2011 | — | — |
Source: AbbVie Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ABBV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
AbbVie Inc. reported 94.58 of price-to-earnings ratio for fiscal 2025. That was 34.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +198.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for AbbVie Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbVie Inc. — frequently asked questions
What is AbbVie Inc.'s price-to-earnings ratio?
AbbVie Inc. (ABBV) reported price-to-earnings ratio of 94.58 for fiscal year 2025, per its SEC filings.
How has AbbVie Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2011 and 2025, ABBV's price-to-earnings ratio grew at roughly 15.6% per year (compound annual rate), from 12.47 to 94.58.
Where does this data come from?
Figures are computed from AbbVie Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More ABBV financial history
Full ABBV fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →